ARCHIVES

ORI Misconduct Findings Announced In Two Cases

This article is from The Cancer Letter archive.

Vol. 22 No. 28 | July 12, 1996

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988

PET Response Can Predict Increased Survival In Patients

April 27, 2012

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010